The Semaglutide Surge: How a diabetes therapy sparked India’s weight loss wave
As demand for GLP-1 therapies explodes, India’s drug regulator moves to curb advertising amid rising concerns over misuse, access, and long-term impact
As demand for GLP-1 therapies explodes, India’s drug regulator moves to curb advertising amid rising concerns over misuse, access, and long-term impact
The decision is based on the phase 3 DESTINY-Breast11 trial
Desidustat tablets are a novel oral HIF-PHI approved for treating anaemia in non-dialysis adult CKD patients
Prostate cancer is one of the fastest-growing cancers in India, with approximately 37,948 new cases each year
If approved, DTX401 would be the first treatment to address the disease at its root cause
Inspection included drug device combinations covering our recent filing in nasal sprays domain
The recommendation covers FYLREVY 14.2 mg and 18.9 mg for non-hysterectomised postmenopausal women experiencing oestrogen deficiency symptoms at least 12 months after their last menses
The facility will bring 850 high-value jobs to the region, including engineers, scientists, operations personnel, and lab technicians
The collaboration centers on the "Life Doesn't Stop for a Hot Flash" campaign
Subscribe To Our Newsletter & Stay Updated